One-Page Truth-Telling Aid for Cancer Disclosure (NCT07730164) | Clinical Trial Compass
RecruitingNot Applicable
One-Page Truth-Telling Aid for Cancer Disclosure
Taiwan400 participantsStarted 2025-11-27
Plain-language summary
The goal of this clinical trial is to learn whether a one-page communication aid can improve communication between physicians and patients with cancer during cancer-related truth-telling consultations. The one-page aid is designed to help physicians quickly understand patients' preferences and needs before the consultation.
The main questions it aims to answer are:
* Does the one-page communication aid improve patients' satisfaction with how cancer-related information is explained?
* Does the one-page communication aid reduce patients' emotional distress after the consultation?
* Does the one-page communication aid improve physicians' confidence in communicating cancer-related information?
Researchers will compare patients whose physicians receive the one-page communication aid with patients whose physicians provide usual care with a blank sheet for patients to write down questions. This comparison will help determine whether the one-page aid improves communication, emotional outcomes, and physician confidence.
Participants will:
* Complete questionnaires before and after the consultation
* Receive either the one-page communication aid or a blank sheet, depending on their physician's group
* Complete follow-up questionnaires at 3 months and 6 months after the consultation
Physicians will also complete brief questionnaires about their communication confidence at baseline, 1 week after recruitment of their first enrolled patient, 3 months, and 6 months.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
【Physicians】
* Inclusion Criteria:
* Physicians who provide clinical care for patients with cancer in participating outpatient departments.
* Physicians who are involved in cancer-related truth-telling or disclosure consultations.
* Physicians who are willing to participate and provide informed consent.
* Exclusion Criteria:
* Physicians who are unable or unwilling to complete study procedures or follow-up assessments.
【Patients】
* Inclusion Criteria:
* Patients diagnosed with cancer.
* Patients who are scheduled to receive cancer-related information from a participating physician, including information about diagnosis, recurrence, metastasis, end-of-life status.
* Patients who are able to communicate in Mandarin Chinese or Taiwanese.
* Patients who are able to complete questionnaires independently or with assistance from the research assistant.
* Patients who are willing to participate and provide informed consent.
* Exclusion Criteria:
* Patients who are unable to provide informed consent.
* Patients with severe cognitive impairment, severe physical illness, or emotional distress that prevents participation, as judged by the clinical team or research staff.
* Patients who are unable to complete the study questionnaires even with assistance.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Patients' Truth-Telling Preferences and Perceptions
Timeframe: Baseline, immediately after the truth-telling consultation, 3 months post-intervention, and 6 months post-intervention